Skip to main content
informCLL™: A Disease Registry for Patients with Chronic Lymphocytic Leukemia
Sponsor: Pharmacyclics LLC

The purpose of the InformCLL Registry is to characterize and describe treatment patterns for those initiating treatment with approved oral kinase inhibitors, BCL-2 inhibitors and other approved anti-CLL /SLL therapies/regimens. This study also evaluates association of treatment patterns with patient characteristics, healthcare resource utilization and patient reported Health related Quality of Life (HRQoL). full clinical trial description



Northern Westchester Hospital
400 East Main StreetMount Kisco, NY 10549